CSIMarket
 

Biofrontera Inc   (NASDAQ: BFRI)

Biofrontera Inc 's

Competitiveness




 

BFRI Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Biofrontera Inc reported Revenue increase in the 1 quarter 2026 by 14.87 % year on year.
The revenue growth was below Biofrontera Inc 's competitors' average revenue growth of 109.62 %, achieved in the same quarter.

List of BFRI Competitors





Revenue Growth Comparisons




Net Income Comparison


Biofrontera Inc recorded a net loss, despite income increase by most of its competitors of 0 %

<<  BFRI Stock Performance Comparisons



  

Overall company Market Share Q1 2026

Despite revenue growth of 14.87 % in Overall company, Biofrontera Inc lost market share within this segment.




<<  More on BFRI Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Biofrontera Inc




Skinvisible Inc
Share Performance



-10.00%
30 Days



Skinvisible Inc
Profile

Skinvisible Inc's business model revolves around the development, licensing, and sale of innovative and patented skincare technologies and formulations for use in various consumer and pharmaceutical applications.

More about Skinvisible Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.973 mill. $ 0.020 mill. $ -1.050 mill.


Medicinova Inc
Share Performance



+4.74%
This Quarter



Medicinova Inc
Profile

Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes.

More about Medicinova Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 70.632 mill. $ 0.597 mill. $ -11.720 mill.


Puma Biotechnology Inc
Share Performance



-0.11%
Over The Past 5 Days



Puma Biotechnology Inc
Profile

Puma Biotechnology Inc operates as a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Their business model revolves around identifying promising preclinical and clinical drug candidates, conducting rigorous research and development, and seeking regulatory approval for their products. Puma Biotechnology Inc strives to effectively market and distribute their approved therapeutics to provide patients with potentially life-saving treatment options.

More about Puma Biotechnology Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 463.199 mill. $ 227.178 mill. $ 24.384 mill.


Teva Pharmaceutical Industries Limited
Share Performance



-2.38%
Over The Past 5 Days



Teva Pharmaceutical Industries Limited
Profile

Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.

More about Teva Pharmaceutical Industries Limited's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 41,998.250 mill. $ 14,105.000 mill. $ 709.000 mill.


Therapeuticsmd Inc
Share Performance



+32.12%
This Year



Therapeuticsmd Inc
Profile

TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.

More about Therapeuticsmd Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 25.375 mill. $ 3.353 mill. $ 0.179 mill.

10 more competitors available

Sign in to see all competitors

Sources: Biofrontera Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Biofrontera Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.